Abbruzzese JL - Search Results

1

Phase II trial of fazarabine in advanced colorectal carcinoma.

Hubbard KP, Daugherty K, Ajani JA, Pazdur R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: abbruzzese jl. Invest New Drugs. 1992 Apr;10(1):39-42. doi: 10.1007/BF01275479. Invest New Drugs. 1992. PMID: 1376722 Clinical Trial.

2

Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer.

Hoff PM, Saad ED, Pazdur R, Wolff R, Lassere Y, Bogaard KR, Abbruzzese JL. Hoff PM, et al. Among authors: abbruzzese jl. Invest New Drugs. 2004 Aug;22(3):307-13. doi: 10.1023/B:DRUG.0000026257.31142.41. Invest New Drugs. 2004. PMID: 15122078 Clinical Trial.

3

A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver.

Jones DV Jr, Patt YZ, Ajani JA, Abbruzzese J, Carrasco CH, Charnsangavej C, Levin B, Wallace S. Jones DV Jr, et al. Cancer. 1993 Nov 1;72(9):2560-3. doi: 10.1002/1097-0142(19931101)72:9<2560::aid-cncr2820720908>3.0.co;2-e. Cancer. 1993. PMID: 8402476 Clinical Trial.

4

Evaluation of continuous-infusion alpha-difluoromethylornithine therapy for colorectal carcinoma.

Ajani JA, Ota DM, Grossie VB Jr, Abbruzzese JL, Faintuch JS, Patt YZ, Jackson DE, Levin B, Nishioka K. Ajani JA, et al. Among authors: abbruzzese jl. Cancer Chemother Pharmacol. 1990;26(3):223-6. doi: 10.1007/BF02897204. Cancer Chemother Pharmacol. 1990. PMID: 2113439

5

A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity.

Abbruzzese JL, Levin B, Ajani JA, Faintuch JS, Pazdur R, Saks S, Edwards C, Gutterman JU. Abbruzzese JL, et al. J Biol Response Mod. 1990 Oct;9(5):522-7. J Biol Response Mod. 1990. PMID: 2123922

6

A phase II study of trimetrexate therapy for metastatic colorectal carcinoma.

Ajani JA, Abbruzzese JL, Faintuch JS, Patt YZ, Boman BM, Jackson DE, Levin B, Krakoff IH. Ajani JA, et al. Among authors: abbruzzese jl. Cancer Invest. 1990;8(6):619-21. doi: 10.3109/07357909009018929. Cancer Invest. 1990. PMID: 2149834 Clinical Trial.

7

Phase II study of fludarabine phosphate in patients with advanced colorectal carcinoma.

Ajani JA, Abbruzzese JL, Faintuch JS, Blackburn R, Levin B, Boman BM. Ajani JA, et al. Among authors: abbruzzese jl. Invest New Drugs. 1988 Apr;6(1):47-50. doi: 10.1007/BF00170780. Invest New Drugs. 1988. PMID: 2457566

8

Treatment of advanced colorectal cancer.

Abbruzzese JL, Levin B. Abbruzzese JL, et al. Hematol Oncol Clin North Am. 1989 Mar;3(1):135-53. Hematol Oncol Clin North Am. 1989. PMID: 2465291 Review.

9

Phase I and II studies of the combination of recombinant human interferon-gamma and 5-fluorouracil in patients with advanced colorectal carcinoma.

Ajani JA, Rios AA, Ende K, Abbruzzese JL, Edwards C, Faintuch JS, Saks S, Gutterman JU, Levin B. Ajani JA, et al. Among authors: abbruzzese jl. J Biol Response Mod. 1989 Apr;8(2):140-6. J Biol Response Mod. 1989. PMID: 2499663

10

Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer.

Abbruzzese JL, Levin B, Ajani JA, Faintuch JS, Saks S, Patt YZ, Edwards C, Ende K, Gutterman JU. Abbruzzese JL, et al. Cancer Res. 1989 Jul 15;49(14):4057-61. Cancer Res. 1989. PMID: 2500234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

501 results

Search Page

Filters